Fuling Technology
001356
KLT
831689
Hand Enterprise Solutions
300170
4
GRANDTECH
835184
5
Doushen(Beijing) Education & Technology Inc.
300010
US Stock MarketDetailed Quotes
TSHA Taysha Gene Therapies
- 1.5300
- 0.00000.00%
Close Jan 22 16:00 ET
- 1.5499
- +0.0199+1.30%
Post 19:15 ET
313.56MMarket Cap2.43P/E (TTM)
1.5699High1.5000Low1.13MVolume1.5400Open1.5300Pre Close1.73MTurnover0.90%Turnover RatioLossP/E (Static)204.94MShares4.320052wk High3.53P/B191.79MFloat Cap1.190052wk Low--Dividend TTM125.35MShs Float33.3500Historical High--Div YieldTTM4.57%Amplitude0.5000Historical Low1.5310Avg Price1Lot Size
Taysha Gene Therapies News
Needham Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $6
Taysha Gene Therapies Analyst Ratings
JMP Securities Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $5
JMP Securities Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $5
Buy Rating for Taysha Gene Therapies Due to Safer Administration Method and Lower Viral Dose
Taysha Gene Therapies Analyst Ratings
CCORF Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Raises Target Price to $8
Taysha Gene Therapies Is Maintained at Buy by Chardan Capital
Taysha Gene Therapies Price Target Maintained With a $6.00/Share by Needham
Cantor Fitzgerald Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $7
BMO Capital Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $5
A Quick Look at Today's Ratings for Taysha Gene Therapies(TSHA.US), With a Forecast Between $5 to $7.5
Taysha Gene Therapies: Promising Developments and Strong Financial Position Support Buy Rating
A Quick Look at Today's Ratings for Taysha Gene Therapies(TSHA.US), With a Forecast Between $5 to $7
Positive Buy Rating for Taysha Gene Therapies Amidst Competitive Advantages Over Neurogene
A Quick Look at Today's Ratings for Taysha Gene Therapies(TSHA.US), With a Forecast Between $5 to $7
Taysha Gene Therapies Price Target Maintained With a $6.00/Share by Needham
Taysha Gene Therapies Analyst Ratings
Baird Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $7
Needham Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $6
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace
Discussing
Trump 2.0 Era: What's the next opportunity in the markets?
▪️Could Trump's crypto policies potentially benefit the crypto market? ▪️Might his tariff policies have a positive effect on Chinese stocks
Michael McCarthy CCO
Jan 3 11:57
Ask a strategist - Trump's first day